ArticleInternational journal of cancer2018

Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.

Stefano Baldoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.